Tamekia sells ATRC 15.59: AtriCure Announces First Patient Enrolled in Stroke Feasibility Study
WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leader in surgical solutions to treat atrial fibrillation (Afib), today announced the first patient enrolled in a feasibility study using the AtriClip® Left Atrial Appendage Exclusion . ... ...
40 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home